The bone-anchored hearing aid (BAHA) is an effective means of intervention, its use being well documented in persons with chronic conductive pathology and congenital aural anomalies. This article describes the standard guidelines (both auditory and extraauditory aspects) for patient selection and expands the criteria to include bilateral BAHA implantation, unilateral conductive hearing loss, and unilateral profound sensorineural hearing loss. The BAHA's development, design features, and patient outcomes are also reviewed. Suggestions are presented for fitting, counseling, and following BAHA users.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1044/1059-0889(2002/011) | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-Term Clinical Outcomes for Bone-Anchored Hearing Implants: 3-Year Comparison Between Minimally Invasive Ponto Surgery and the Linear Incision Technique With Tissue Preservation.
Otol Neurotol
February 2025
Department of Otorhinolaryngology-Head and Neck Surgery, Donders Center for Neuroscience, Radboud University Medical Center, Radboud University, Nijmegen, the Netherlands.
Objective: To compare the 3-year outcomes of the modified minimally invasive Ponto surgery (m-MIPS) to both the original MIPS (o-MIPS) and linear incision technique with soft tissue preservation (LIT-TP) for inserting bone-anchored hearing implants (BAHIs).
Study Design: Prospective study with three patient groups: m-MIPS, o-MIPS, and LIT-TP.
Setting: Tertiary referral center.
Effect analysis of unilateral deaf adults wearing bone-conduction hearing aids: A case report.
J Otol
October 2024
Department of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital, Beijing, China.
The prevalence of unilateral deafness (SSD) or asymmetric hearing loss (AHL) among patients with hearing impairments ranges from 7.2% to 15.0%, indicating a relatively significant proportion.
View Article and Find Full Text PDFAuditory and Speech Outcomes Following Transcutaneous Bone Conduction Hearing Implantation.
Cureus
November 2024
Otolaryngology- Head and Neck Surgery, King Abdulaziz University Faculty of Medicine, Jeddah, SAU.
Objectives: Implantable bone conduction hearing devices offer excellent auditory rehabilitation. Transcutaneous devices, which use an implanted magnet, are gaining popularity due to higher skin complications associated with traditional percutaneous devices. The Cochlear Baha® Attract System (Cochlear Corporation, Sydney, Australia) is a transcutaneous device and is regarded as a passive transcutaneous implant.
View Article and Find Full Text PDFAssessment of TISA "Transcutaneous Implant Skin Anomalies" scale for cutaneous complications related to bone conduction hearing implants.
Am J Otolaryngol
December 2024
Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia. Electronic address:
Objective: To describe the use of the TISA (Transcutaneous Implant Skin Anomalies) scale by members of the Colombian Association of Otology (ACON) in the evaluation of patients using bone conduction implants.
Methods: A cross-sectional descriptive observational study was conducted among the members of the Colombian Association of Otology. A voluntary survey was performed, where participants evaluated images of patients with transcutaneous bone conduction implants exhibiting different skin conditions.
Hearing Device Coil Placement Lateral to the Temporalis: An Alternative to Flap Thinning for Cochlear and Transcutaneous Bone-Anchored Implants.
Otol Neurotol
January 2025
Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!